Page 109 - Immunization Practices News Today

The vaccine should be available in the fall.

The vaccine should be available in the fall.

The vaccine should be available in the fall.

The FDA on Wednesday approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one.

The vaccine should be available in the fall.

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.

The vaccine should be available in the fall.

The vaccine should be available in the fall.

A vaccine that was developed by Pfizer and aimed at the same demographic as GSK's Arexvy is expected to be approved by the end of the month.

The end of an era looms for employee benefits plans, as the Biden administration has announced the end of both the Public Health Emergency and the National Emergency periods on May 11,...